Nature Medicine
10, 145 - 147 (2004)
Published online: 25 January 2004; | doi:10.1038/nm988
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G Duda, Lance L Munn, Ricky T Tong, Daniel C Chung, Dushyant V Sahani, Sanjeeva P Kalva, Sergey V Kozin, Mari Mino, Kenneth S Cohen, David T Scadden, Alan C Hartford, Alan J Fischman, Jeffrey W Clark, David P Ryan, Andrew X Zhu, Lawrence S Blaszkowsky, Helen X Chen, Paul C Shellito, Gregory Y Lauwers
& Rakesh K JainSupplementary Fig. 1 (pdf 142K) Supplementary Fig. 2 (pdf 113K) Supplementary Note (pdf 15K) Supplementary Table 1 (pdf 9K)
|
